Literature DB >> 31604155

Antagonistic trait of Lactobacillus reuteri S5 against Salmonella enteritidis and assessment of its potential probiotic characteristics.

Shuiqin Shi1, Zhao Qi2, Tingting Sheng3, Jian Tu4, Yin Shao5, Kezong Qi6.   

Abstract

Salmonella enteritidis is an important foodborne pathogen that has caused multiple outbreaks of infection associated with poultry and egg consumption. Thus, the prevention and inhibition of Salmonella enteritidis infection are of great concern. Lactic acid bacteria have anti-pathogenic activity; however, their underlying mechanisms and modes of action have not yet been clarified. In this study, the antibacterial mechanism of Lactobacillus reuteri S5 (L. reuteri S5) against Salmonella enteritidis ATCC13076 (S. enteritidis ATCC13076) was studied by different methods. We found that L. reuteri S5 was able to form a stable biofilm formation, colonizing the entire intestinal tract of chickens. In addition, bacterial cultures and the cell-free supernatant (CFS) of L. reuteri S5 inhibited SE ATCC13076 growth, and this growth inhibition was also observed in the co-culture assay. This effect may be predominantly caused by antimicrobial metabolites produced by L. reuteri S5. Furthermore, treatment with the CFS of L. reuteri S5 resulted in a significant reduction in the expression of Salmonella virulence, motility and adhesion genes and a significant reduction in the motility ability and inhibitory effect on biofilm formation. In addition, the damage to the membrane structure and intracellular structure induced by the CFS of L. reuteri S5 could be observed on Transmission electron microscopy images and dodecyl sulfate, sodium salt (SDS)-Polyacrylamide gel electrophoresis confirmed the disruptive action of the CFS of L. reuteri S5 on the cytoplasmic membrane. Our findings demonstrate that L. reuteri S5, an intestinal Lactobacillus species associated with chicken health, is able to form biofilm and stably colonize chicken intestines. It also possesses anti-SE activity, preventing SE growth, inhibits the expression of SE genes involved in adhesion and invasion, virulence and cell membrane integrity, inhibits SE biofilm formation and motility, damages or destroys bacterial structures, and inhibits intracellular protein synthesis. L. reuteri S5 therefore has potential applications as a probiotic agent.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial mechanism; Biofilms formation; Intestinal colonization; Lactobacillus reuteri S5; Salmonella enteritidis ATCC13076

Mesh:

Substances:

Year:  2019        PMID: 31604155     DOI: 10.1016/j.micpath.2019.103773

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  4 in total

1.  Antagonistic activity and mechanism of Lactobacillus rhamnosus SQ511 against Salmonella enteritidis.

Authors:  Shuiqin Shi; Li Gong; Hao Yu; Guangyu He; Jingjing Zhang; Yu Han; Yannan Liu; Jie Hu; Jinsheng Dong; Jia Liu; Kai Zhao; Duoqi Zhou
Journal:  3 Biotech       Date:  2022-05-11       Impact factor: 2.893

2.  Bacillus subtilis and lactic acid bacteria improve the growth performance and blood parameters and reduce Salmonella infection in broilers.

Authors:  Nalisa Khochamit; Surasak Siripornadulsil; Peerapol Sukon; Wilailak Siripornadulsil
Journal:  Vet World       Date:  2020-12-16

3.  Effect of Lactobacillus reuteri S5 Intervention on Intestinal Microbiota Composition of Chickens Challenged with Salmonella enteritidis.

Authors:  Shuiqin Shi; Duoqi Zhou; Yuan Xu; Jinsheng Dong; Yu Han; Guangyu He; Wenhui Li; Jie Hu; Yannan Liu; Kai Zhao
Journal:  Animals (Basel)       Date:  2022-09-22       Impact factor: 3.231

4.  Lactobacillus reuteri and Enterococcus faecium from Poultry Gut Reduce Mucin Adhesion and Biofilm Formation of Cephalosporin and Fluoroquinolone-Resistant Salmonella enterica.

Authors:  Abubakar Siddique; Sara Azim; Amjad Ali; Fazal Adnan; Maryum Arif; Muhammad Imran; Erika Ganda; Abdur Rahman
Journal:  Animals (Basel)       Date:  2021-12-01       Impact factor: 2.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.